Hyalex Orthopaedics, a privately held medical device company developing cartilage repair products based on the transformative HYALEX® materials platform, today announced that patients have successfully received HYALEX Knee Implants as part of the company's first-in-human clinical trials of its novel HYALEX Knee Cartilage System. The company is currently running the two prospective, multi-center, single-arm studies in the U.S. and Europe, with sites for both studies having already enrolled and tr

Related Keywords

United States , New York , Oregon , Poland , Warsaw , L67 , Portland , Hospital For Special Surgery , Carl Vause , Tim Brons , Marcin Domzalski , Oregon Health Science University , Drug Administration , University Of Lodz , Sport Center , Cartilage System , Oregon Health , Science University , Special Surgery , Enel Sport Center , Professor Marcin Domzalski , Chief Executive Officer , Investigational Device Exemption , United States Food , Strategic Partners , Knee Cartilage , Hyaline Cartilage , Cartilage Repair , Orthopaedics , Asymptomatic Patients , Yalex Knee System , Europe , Medical Device Company ,